The role of TREX1 for innate sensing human endogenous retroviruses
The role of TREX1 for innate sensing human endogenous retroviruses
批准号:
318196085
负责人:
Professor Dr. Oliver T. Fackler, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HIV-1 reverse transcription (RT) products are predominantly sensed in most cell types by the cyclic GMP-AMP synthase cGAS-STING pathway. The host cell cytoplasmic exonuclease TREX1 was described to metabolize exogenous retroviral RT products in the cytoplasm of mammalian cells and studies in trex1 knock-out mice suggested that TREX1 has an important role in the elimination of ERV RT products as well as of cytoplasmic DNA products resulting from DNA damage. Based on these results reported in the literature, a central hypothesis of this project was that TREX1 plays a central role in controlling innate (auto) immune responses by lowering the amounts of retroviral and cellular cytoplasmic DNA to avoid innate immune sensing. Work in the first funding period established innate immune sensing competent and –incompetent cell systems with or without TREX1 expression for the analysis of TREX1 function in response to infection with exogenous retrovirus or upon induction of expression of endogenous retroviruses or DNA damage. In parallel, assays were established for the quantification of enzymatic activities of TREX1 in vitro and their immunological consequences in cells. Finally, the analysis of TREX1 expression in human cells yielded an unexpectedly complex pattern of cell-type and stimulation-dependent expression of various TREX1 isoforms that differ in their substrate specificity and revealed that TREX1 can be subject to proteolytic cleavage. Work in the second funding period will build on these tools and findings to achieve a comprehensive understanding of the role of diverse TREX1 isoforms and processing products in human cells in the context of retrovirus infection and DNA damage. Since TREX1 is a transmembrane protein localized at the endoplasmic reticulum as well as in the nucleus, another central question is how and where the exonuclease has access to retroviral RT products. To address these questions, we will conduct (i) a comprehensive functional characterization of TREX1 isoforms and cleavage products and (ii) dissect the immunological consequences of the metabolism of cytoplasmic DNA. These analyses will systematically compare exogenous infections with HIV-1 with the induction of ERV expression or DNA damage. Together, we aim at providing novel tempo-spatial and mechanistic insight in the interplay between TREX1 and retroviral replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antagonism of Host Cell Restriction and Sensing by HIV-1 Nef
-
批准号:318144338
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Coordination Funds
-
批准号:318211563
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Role of the Diaphanous Formin FHOD1 and its interaction with nesprin-2-giant in nuclear migration
-
批准号:267922142
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Mechanisms of cell motility inhibition by the HIV-1 pathogenesis factor NEF
-
批准号:180582868
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Characterization of the antiviral immunity factor CD317/tetherin
-
批准号:163617427
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Rho GTPases and Diaphanous related Formins in HIV-1 replication
-
批准号:45277349
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Regulationsmechanismen und physiologische Funktion des Diaphanous Formins FHOD1
-
批准号:25964824
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Design und Charakterisierung eines Moleküls zur Inhibierung des HIV Pathogenesefaktors Nef
-
批准号:5396103
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Analyse der molekularen Mechanismen des Pathogenitätsfaktors Nef des Humanen Immundefizienzvirus Typ 1 (HIV-1)
-
批准号:5287522
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Role of lncRNAs in cell activation, actin remodeling and HIV latency in CD4 T lymphocytes
-
批准号:508136175
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Mechanisms of actin polymerization in T lymphocyte nuclei
-
批准号:387759352
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
Characterization of HIV infection in resting CD4 T-cells
-
批准号:259021520
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Oliver T. Fackler, Ph.D.
-
依托单位:
国内基金
海外基金
登录
查看更多内容
甘草查尔酮B调控cGAS-STING通路治疗TREX1基因缺陷自身炎症性疾病的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
GLIS1介导TREX1通过负性调控cGAS-STING通路抑制肝细胞癌CD8+T细胞活化的功能及机制研究
-
批准号:82303322
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:荣大伟
-
依托单位:
探索MSI-H肿瘤内源TREX1调控抗肿瘤免疫的机制及相关免疫治疗策略开发
-
批准号:82371848
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2023
-
负责人:韩传辉
-
依托单位:
P4HA3通过TREX1脯氨酸羟基化抑制免疫原性细胞死亡在前列腺癌恩杂鲁胺耐药中的作用机制研究
-
批准号:82303917
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:温耀安
-
依托单位:
树突状细胞特异性 cGas 对 Trex1 缺失所致系统性自身免疫反应的作用及机制研究
-
批准号:2022JJ40824
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:吴俊娇
-
依托单位:
TREX1调节天然免疫及相关疾病的机理研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:周稳
-
依托单位:
TREX1抑制剂IM502通过激活STING信号通路调控结肠癌肿瘤微环境的作用机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:胡静
-
依托单位:
人TREX1蛋白调控HIV Tat蛋白稳定性的现象及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:杜娟
-
依托单位:
Trex1 m6A去甲基化修饰在肝癌放疗诱导的抗肿瘤免疫效应中的作用及其机制研究
-
批准号:82102823
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:赵倩倩
-
依托单位:
去甲基化酶ALKBH5介导的TREX1 m6A修饰调控cGAS-STING信号通路促进放射性肝损伤的机制
-
批准号:82073334
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:曾昭冲
-
依托单位: